Abstract:Background: Nuclear factor interleukin 3 (NFIL3) mainly focuses on the regulation of the circadian rhythm and immune system. However, the potential role of NFIL3 in human cancers has not been studied extensively. Methods: We retrieved original data from the TCGA, TARGET, and GTEx datasets via the UCSC Xena browser (http://genome.ucsc.edu/) and integrated them using R version 3.6.4. NFIL3 expression was assessed using resources such as UCSC, GEPIA (http://gepia.cancer-pku.cn/), Kaplan-Meier Plotter (KM Plotter; https://kmplot.com/), and the Human Protein Atlas (HPA; https://www.proteinatlas.org/) databases. To investigate the prognostic implications of NFIL3, we utilized GEPIA, Kaplan-Meier Plotter, and PrognoScan (http://www.abren.net/PrognoScan/) datasets. For a comprehensive analysis across multiple cancer types, we employed pan-cancer data from UCSC, examining associations between NFIL3 expression and genomic heterogeneity, tumor mutational burden (TMB), microsatellite instability (MSI), tumor purity, and neoantigens. Furthermore, we explored the relationships between NFIL3 expression and the infiltration of immune cells and the expression of immune checkpoint genes. In the context of ovarian cancer, we validated the expression and functional relevance of NFIL3. Cell Counting Kit 8 (CCK8) assays were conducted to assess cell proliferation, while scratch and transwell assays were employed to evaluate cell migration capabilities. We further examined the interaction between NFIL3 and the p53 signaling pathway through quantitative real-time polymerase chain reaction (qRT-PCR), Western blot analysis, immunofluorescence confocal, and Coimmunoprecipitation (Co-IP) assays. Results: In general, NFIL3 expression in cancerous tissues exhibited diminished levels when compared to normal tissue samples. Notably, NFIL3 expression demonstrated a robust correlation with several pivotal aspects, including prognosis, immune cell infiltration, immune checkpoint-related genes, TMB, MSI, tumor purity, and the presence of neoantigens. Experimental investigations involving scratch assays, transwell assays, and assessments of cell proliferation in ovarian cancer cells have provided indications that NFIL3 may exert influence over cell migration and proliferation processes. Moreover, a substantial association between NFIL3 and the p53 signaling pathway was discerned through Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, with subsequent validation through qRT-PCR, Western blot analysis, immunofluorescence confocal, and co-immunoprecipitation (Co-IP) assays. Conclusions: Therefore, we concluded NFIL3 may serve as a possible prognostic and immunological pan-cancer biomarker.

Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.

Gene‐expression Profiling in Chinese Patients with Colon Cancer by Coupling Experimental and Bioinformatic Genomewide Gene‐expression Analyses

Identification of IFITM1 with prognostic value in pancreatic cancer using network module-based analysis

Identification of IFN-Induced Transmembrane Protein 1 with Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis.

Screening for Candidate Genes Related to Breast Cancer with Cdna Microarray Analysis

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Identification and Experimental Verification of a Biomarker by Combining the Unfolded Protein Response with the Immune Cells in Colon Cancer

Screening the Tumor-Associated Genes by Integrate Analysis of Gene Expression Profiling of Colon Carcinoma

High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia

Knockdown of Interferon-Induced Transmembrane Protein 3 Expression Suppresses Breast Cancer Cell Growth and Colony Formation and Affects the Cell Cycle.

IFITM10 Enhance Tumor Angiogenesis and Promotes Cancer Progression through STAT3 Activation

Expression of Insulin-Like Growth Factor- II Mrna-Binding Protein 3 in Colon Cancer and Its Implication

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma.

Prognostic Significance of INF-induced Transmembrane Protein 1 in Colorectal Cancer.

Highly Expressed IFITM10 is Associated with Early Diagnosis and T Stage of Gastric Cancer

Overexpression of Eif3e is Correlated with Colon Tumor Development and Poor Prognosis.

Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer

A pan-cancer characterization of immune-related NFIL3 identifies potential predictive biomarker

Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches

An integrative analysis reveals the prognostic and immunological role of TIMP gene family in pan-cancer